Clinical trial in duchenne dystrophy. I. The design of the protocol
Michael H. Brooke, Richard J. Pellegrino(University of California, Los Angeles), Robert C. Griggs(University of Rochester), Gerald M. Fenichel(Vanderbilt University), Jack B. Shumate, Jerry R. Mendell(Nationwide Children's Hospital)
Cited by 563
Related Papers
Evidence‐based path to newborn screening for duchenne muscular dystrophy
|Annals of Neurology|2012|816
Eteplirsen for the treatment of Duchenne muscular dystrophy
|Annals of Neurology|2013|793
Dystrophin Immunity in Duchenne's Muscular Dystrophy
|New England Journal of Medicine|2010|655
Myoblast Transfer in the Treatment of Duchenne's Muscular Dystrophy
|New England Journal of Medicine|1995|522
Randomized, Double-Blind Six-Month Trial of Prednisone in Duchenne's Muscular Dystrophy
|New England Journal of Medicine|1989|518